Literature DB >> 1699980

The mast cell in health and disease.

M J Rothe1, M Nowak, F A Kerdel.   

Abstract

The presence of mast cells, often in an activated state or increased numbers, has been noted in various cutaneous disorders. Recent studies suggest that mast cells are of primary importance in these conditions and their presence does not merely represent a secondary event. This review focuses on atopic dermatitis, contact hypersensitivity reactions, bullous pemphigoid, fibrosing conditions, neurofibromatosis, wound healing, polycythemia vera, and psoriasis, in which there is significant evidence to indicate a pathophysiologic role for mast cells.

Entities:  

Mesh:

Year:  1990        PMID: 1699980     DOI: 10.1016/0190-9622(90)70264-i

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  19 in total

1.  Protein kinase C: a target for anti-inflammatory therapy?

Authors:  U Amon; K R Dietz
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  Immunohistochemical studies with skin mast cells.

Authors:  B Schmolke; U Amon; N Zemcke; H H Wolff
Journal:  Agents Actions       Date:  1994-06

3.  Skin mast cell releasability in dogs with atopic dermatitis.

Authors:  F DeMora; G García; A Puigdemont; M Arboix; L Ferrer
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

Review 4.  Tryptase as a polyfunctional component of mast cells.

Authors:  Dmitri Atiakshin; Igor Buchwalow; Vera Samoilova; Markus Tiemann
Journal:  Histochem Cell Biol       Date:  2018-03-12       Impact factor: 4.304

5.  Regulatory effects of cytokine production in atopic allergic reaction by gammi-danguieumja.

Authors:  Ho-Jeong Na; Hye-Young Shin; Na-Hyung Kim; Mi-Won Kwon; Eun-Jeong Park; Seung-Heon Hong; Nam-Il Kim; Hyung-Min Kim
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

6.  Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines.

Authors:  Gyi Aung; François Niyonsaba; Hiroko Ushio; Naoki Kajiwara; Hirohisa Saito; Shigaku Ikeda; Hideoki Ogawa; Ko Okumura
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

7.  Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma.

Authors:  Z Qu; J M Liebler; M R Powers; T Galey; P Ahmadi; X N Huang; J C Ansel; J H Butterfield; S R Planck; J T Rosenbaum
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

8.  Direct activation of mast cells by prosthetic biomaterial particles.

Authors:  N Al-Saffar; H Iwaki; P A Revell
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

9.  Mast cells enhance contraction of three-dimensional collagen lattices by fibroblasts by cell-cell interaction: role of stem cell factor/c-kit.

Authors:  T Yamamoto; K Hartmann; B Eckes; T Krieg
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

10.  Monoclonal antibodies to leucosialin (CD43) induce homotypic aggregation of the human mast cell line HMC-1: characterization of leucosialin on HMC-1 cells.

Authors:  S Weber; B Ruh; E Dippel; B M Czarnetzki
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.